P-24 A prospective phase 1b dose de-escalation open-label clinical study to evaluate the safety and efficacy of sorafenib with metformin and atorvastatin in advanced hepatocellular carcinoma (SMASH)

Autor: Bhargava, P., Ostwal, V., Ramaswamy, A., Srinivas, S., Mandavkar, S., Naughane, D., Gota, V., Patkar, S., Goel, M., Banavali, S., Shetty, N.
Zdroj: In Annals of Oncology July 2021 32 Supplement 3:S104-S104
Databáze: ScienceDirect